open access

Vol 21, No 3 (2017)
Original paper
Published online: 2017-09-29
Get Citation

Metabolic syndrome in male population of the Warmia and Masuria region in Poland

Martyna Szczubełek, Piotr Zielecki, Norbert Kwella, Tomasz Stompór, Joanna Harazny
·
Arterial Hypertension 2017;21(3):148-152.

open access

Vol 21, No 3 (2017)
ORIGINAL PAPERS
Published online: 2017-09-29

Abstract

Background. The objective of the study was to evaluate the prevalence of metabolic syndrome (MS) in male population of the Warmia and Masuria region in Poland according to IDF 2005 recommendations.

Material and methods. 631 men, aged 19–82 years (mean 47 } 14) were examined between Dec 2014 and Dec 2016. Standardized questionnaire was completed by the subjects. Anthropometric measurements were performed. Blood pressure was measured. Blood tests (serum fasting glucose, lipidogram) were performed in 398 men (age: 48 } 13years). Following age groups were identified: < 30YOA, 30–47YOA, 48–64YOA, ≥ 65YOA. Two groups of 398 men were defined: MS+ who fulfilled MS criteria, MS- who did not fulfill MS criteria.

Results. MS was diagnosed in 45.7% of 398 men. There was a significant age-related increase in its prevalence: < 30years of age (YOA) 9.5%, 30–47YOA 38.1%, 48–64YOA 53.2%, ≥ 65YOA 65.8%. Prevalence of components of MS in study group (n = 398) was: waist circumference (≥ 94 cm) in 254 (63.8%); high triglycerides (≥ 150 mg/dl or hypertriglyceridemia treatment) in 146 (36.7%); low HDL (< 40 mg/dl or dyslipidemia treatment) in 83 (20.9%); fasting glucose (≥ 100 mg/dl or diabetes treatment) in 173 (43.5%); elevated blood pressure (SBP ≥ 130 mmHg or DBP ≥ 85 mmHg or treatment of hypertension) in 313 (78.6%).

Conclusions. The prevalence of MS in male population of Warmia and Masuria was 45.7% with significant increase in age. The study confirms the necessity of early prevention of MS in that region of Poland.  

Abstract

Background. The objective of the study was to evaluate the prevalence of metabolic syndrome (MS) in male population of the Warmia and Masuria region in Poland according to IDF 2005 recommendations.

Material and methods. 631 men, aged 19–82 years (mean 47 } 14) were examined between Dec 2014 and Dec 2016. Standardized questionnaire was completed by the subjects. Anthropometric measurements were performed. Blood pressure was measured. Blood tests (serum fasting glucose, lipidogram) were performed in 398 men (age: 48 } 13years). Following age groups were identified: < 30YOA, 30–47YOA, 48–64YOA, ≥ 65YOA. Two groups of 398 men were defined: MS+ who fulfilled MS criteria, MS- who did not fulfill MS criteria.

Results. MS was diagnosed in 45.7% of 398 men. There was a significant age-related increase in its prevalence: < 30years of age (YOA) 9.5%, 30–47YOA 38.1%, 48–64YOA 53.2%, ≥ 65YOA 65.8%. Prevalence of components of MS in study group (n = 398) was: waist circumference (≥ 94 cm) in 254 (63.8%); high triglycerides (≥ 150 mg/dl or hypertriglyceridemia treatment) in 146 (36.7%); low HDL (< 40 mg/dl or dyslipidemia treatment) in 83 (20.9%); fasting glucose (≥ 100 mg/dl or diabetes treatment) in 173 (43.5%); elevated blood pressure (SBP ≥ 130 mmHg or DBP ≥ 85 mmHg or treatment of hypertension) in 313 (78.6%).

Conclusions. The prevalence of MS in male population of Warmia and Masuria was 45.7% with significant increase in age. The study confirms the necessity of early prevention of MS in that region of Poland.  

Get Citation

Keywords

metabolic syndrome, prevalence, male population

About this article
Title

Metabolic syndrome in male population of the Warmia and Masuria region in Poland

Journal

Arterial Hypertension

Issue

Vol 21, No 3 (2017)

Article type

Original paper

Pages

148-152

Published online

2017-09-29

Page views

670

Article views/downloads

858

DOI

10.5603/AH.2017.0020

Bibliographic record

Arterial Hypertension 2017;21(3):148-152.

Keywords

metabolic syndrome
prevalence
male population

Authors

Martyna Szczubełek
Piotr Zielecki
Norbert Kwella
Tomasz Stompór
Joanna Harazny

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl